EP2893929
Seftólósan-sýklalyfjasamsetningar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
14.3.2014EP published:
16.4.2025EP application number:
14199792.4
EP translation filed:
25.6.2025Grant published:
15.7.2025EPO information:
European Patent Register
Max expiry date:
13.3.2034Expiry date:
13.3.2027Next due date:
31.3.2027
Title in English:
Ceftolozane antibiotic compositionsLanguage of the patent:
English
Timeline
Today
14.3.2014EP application
16.4.2025EP Publication
25.6.2025Translation submitted
15.7.2025Registration published
13.3.2027Expires
Owner
Name:
Merck Sharp & Dohme LLCAddress:
126 East Lincoln Avenue, Rahway, New Jersey 07065, US
Inventor
Name:
Damour, Nicole MillerAddress:
Lexington, MA Massachusetts 02421, US
Name:
Terracciano, JosephAddress:
Lexington, MA Massachusetts 02421, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201361792092 PDate:
15.3.2013Country:
US
Number:
201361793007 PDate:
15.3.2013Country:
US
Number:
201361882936 PDate:
26.9.2013Country:
US
Number:
201361893436 PDate:
21.10.2013Country:
US
Classification
Categories:
A61K 31/546, A61K 31/431, A61P 31/00, A61P 31/04, A61K 47/02, A61K 47/12, A61K 47/18, A61K 9/19, A61K 9/00
Annual fees
Number
Paid
Expires
Payer
Number: 13
Paid: 5.3.2026
Expires: 13.3.2027
Payer: Árnason Faktor ehf.